Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001641172-25-011814
Filing Date
2025-05-20
Accepted
2025-05-20 17:29:11
Documents
4
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 6-K form6-k.htm 6-K 31149
2 EX-99.1 ex99-1.htm EX-99.1 392240
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4622
4 GRAPHIC ex99-1_002.jpg GRAPHIC 32693
  Complete submission text file 0001641172-25-011814.txt   476407
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
COSCIENS Biopharma Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 25970146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)